Neuroimaging Market is expected to grow at a CAGR of 8.1% during the forecasted period | Evolve Business Intelligence

As per the study initiated by Evolve Business Intelligence, the global Neuroimaging Market size accounted for USD 40.1 Billion in 2023, growing at a CAGR of 8.1% from 2023 to 2033. Neuroimaging is a field of medical imaging that focuses on the structure and function of the brain. It involves various techniques to visualize and measure brain activity, structure, and function. These techniques help researchers and healthcare professionals understand the underlying mechanisms of neurological and psychiatric disorders, as well as normal brain function.
Request/Download PDF Sample: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021459
The rise in the prevalence of neurological disorders, such as Alzheimer's disease, Parkinson's disease, and stroke, has increased the demand for neuroimaging techniques for early diagnosis and effective treatment planning. Ongoing technological advancements in neuroimaging techniques, such as higher resolution and faster imaging, contribute to market growth by improving diagnostic accuracy and efficiency. The aging global population is associated with a higher incidence of neurological disorders, driving the need for advanced diagnostic tools like neuroimaging. Increasing awareness among healthcare professionals and patients about the benefits of early detection and intervention in neurological disorders has led to greater acceptance and utilization of neuroimaging technologies.
Key Players
Some of the major Neuroimaging Market players holding high market shares include GE Healthcare, Siemens Healthineers, Philips Healthcare, Toshiba Medical Systems Corporation, Hitachi Healthcare, Canon Medical Systems Corporation, Mindray Medical International Limited, and Esaote SpA. These players use partnership and collaboration as a key strategy to gain significant market share to compete with market leaders. Some of the other major market players include NeuroLogica Corporation, NeuroVive Pharmaceutical AG, Brainlab AG, Akili Interactive Labs Inc., Brainomix Ltd., Imaging Science International, Mevis Medical Solutions, NeuroVista, Neusoft Medical Systems, Positron Corporation, Shimadzu Corporation, Trifoil Imaging
For More Information: https://report.evolvebi.com/index.php/sample/request?referer=OpenPR&reportCode=021459
Segmental Analysis
Based on image type, the Neuroimaging market is segmented into Structural Imaging, Functional Imaging, and Hybrid Imaging. Structural imaging is the largest segment of the Neuroimaging market. This is because structural imaging techniques, such as MRI and CT, are widely used to diagnose a wide range of neurological conditions.
Based on technology, the Neuroimaging market is Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography (PET), Single Photon Emission Computed Tomography (SPECT), Functional Magnetic Resonance Imaging (fMRI), Diffusion Tensor Imaging (DTI), Magnetoencephalography (MEG), Electroencephalography (EEG), Others. MRI is the largest segment of the Neuroimaging market. This is because MRI is a non-invasive imaging modality that provides high-quality images of the brain and spinal cord.
Based on application, the Neuroimaging market is a Neurological Disorders, Psychiatric Disorders, Traumatic Brain Injury (TBI), Brain Tumors, and Others. Neurological disorders are the largest segment of the Neuroimaging market. This is because neuroimaging is an essential tool for the diagnosis and management of neurological disorders, such as stroke, Alzheimer's disease, and Parkinson's disease.
Based on End Use, the Neuroimaging market is Hospitals and Clinics, Diagnostic Centers, Research Institutes, Ambulatory Surgical Centers, and Others. Hospitals and clinics are the largest segments of the Neuroimaging market. This is because hospitals and clinics are the primary providers of neuroimaging services.
Key Region/ Countries Covered
• North America (US, Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Spain, Russia, Nordic Countries, BeNeLux, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Rest of Asia Pacific)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, South Africa, Rest of MEA)
• Latin America (Mexico, Brazil, Argentina, Rest of Latin America)

Address
Evolve Business Intelligence
C-218, 2nd floor, M-Cube
Gujarat 396191
India
Email: sales@evolvebi.com
Website: https://evolvebi.com/

About EvolveBI
Evolve Business Intelligence is a market research, business intelligence, and advisory firm providing innovative solutions to challenging pain points of a business. Our market research reports include data useful to micro, small, medium, and large-scale enterprises. We provide solutions ranging from mere data collection to business advisory.
Evolve Business Intelligence is built on account of technology advancement providing highly accurate data through our in-house AI-modelled data analysis and forecast tool - EvolveBI. This tool tracks real-time data including, quarter performance, annual performance, and recent developments from Fortune's global 2000 companies.

This release was published on openPR.